Avanos Medical to delist common stock from NYSE
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Avanos Medical, Inc. is removing its common stock from listing and registration on the New York Stock Exchange under Section 12(b) of the Securities Exchange Act of 1934. The exchange states it has complied with its own rules for striking the class of securities, and the company has complied with exchange rules and 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the common stock from listing and registration.
Key Terms
Section 12(b) regulatory
Form 25 regulatory
voluntary withdrawal regulatory
17 CFR 240.12d2-2(c) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 25 filing mean for Avanos Medical (AVNS)?
Which Avanos Medical (AVNS) securities are affected by this action?
Is the Avanos Medical (AVNS) NYSE delisting described as voluntary?
What role does the New York Stock Exchange play in the Avanos Medical (AVNS) delisting?
Which regulations are referenced in the Avanos Medical (AVNS) Form 25?
AI-generated analysis. How Rhea-AI works. Not financial advice.